Could renal parenchymal diffuse echogenic foci on the inferior pole be scar tissue from a partial nephrectomy (surgical removal of part of the kidney) for angiomyolipoma (a type of non-cancerous kidney tumor) 12 years ago?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Echogenic Foci After Partial Nephrectomy: Likely Postoperative Changes

Yes, the diffuse echogenic foci measuring 0.54 and 0.57 cm on the inferior pole are most likely postoperative scar tissue or fibrotic changes from your partial nephrectomy 12 years ago, especially given their small size, lack of posterior acoustic shadowing, and location at the surgical site.

Why These Findings Suggest Scar Tissue

The characteristics you describe are consistent with postoperative changes rather than concerning pathology:

  • Small size (<1 cm): Both lesions are well below the 4 cm threshold where intervention is typically considered for angiomyolipomas 1, 2
  • Lack of posterior shadowing: True angiomyolipomas with significant fat content often demonstrate acoustic shadowing on ultrasound, which your lesions do not show 3
  • Location at surgical site: The inferior pole matches your previous partial nephrectomy site, making postoperative fibrosis the most parsimonious explanation 4
  • Diffuse pattern: Scar tissue typically appears as diffuse echogenic changes rather than discrete masses 2

Recommended Surveillance Approach

For echogenic foci <4 cm in a post-nephrectomy kidney, ultrasound surveillance every 3 years is appropriate, as the risk of spontaneous hemorrhage or malignant transformation is extremely low at this size 2:

  • Continue using ultrasound as your primary surveillance modality for consistency in measurements, as switching between imaging modalities (ultrasound, CT, MRI) can create false impressions of growth or stability 5, 1, 2
  • If these lesions remain stable in size and appearance over time, this further supports their benign postoperative nature 2
  • Monitor your remaining kidney function with periodic serum creatinine and estimated glomerular filtration rate (eGFR), as partial nephrectomy patients require ongoing renal function assessment 2

When to Escalate Imaging

You should obtain CT or MRI for better characterization only if 2:

  • The lesions grow >5 mm per year on serial ultrasounds
  • Ultrasound characteristics change (new enhancement patterns, increased vascularity)
  • New symptoms develop (flank pain, hematuria)
  • The lesions reach 4 cm or larger, at which point MRI or CT every 6-12 months becomes indicated due to increased bleeding risk 5, 1

Important Caveats

While scar tissue is the most likely explanation, be aware that:

  • Not all hyperechoic lesions are benign: Up to 8% of renal cell carcinomas can appear hyperechoic on ultrasound, though these typically show other distinguishing features like a hypoechoic rim or cystic regions 2, 3
  • Recurrent angiomyolipomas are possible: Although rare, angiomyolipomas can recur after partial nephrectomy, and multicentricity occurs in some cases 6, 4
  • Fat-poor lesions may be isoechoic: Some angiomyolipomas lack sufficient fat to appear hyperechoic, making them harder to detect on ultrasound 1

What Your Radiologist Should Document

Ensure your follow-up ultrasound reports include:

  • Precise measurements of both lesions using the same technique each time 5, 2
  • Assessment of echogenicity relative to renal parenchyma and sinus fat 3
  • Presence or absence of posterior acoustic shadowing 3
  • Vascularity on color Doppler if performed 1
  • Comparison to prior imaging to establish stability 2

Given the 12-year interval since surgery, small size, and typical location, these findings almost certainly represent benign postoperative changes rather than new pathology requiring intervention.

References

Guideline

Angiomyolipoma (AML) on Kidney Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Follow-up for Small Echogenic Foci After Renal Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Criteria for ultrasound differentiation of small angiomyolipomas (< or = 3 cm) and renal cell carcinomas].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998

Guideline

MRI for Angiomyolipoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.